Zoetis Inc. (ZTS) Stock Forecast

NYSE: ZTSAnalyst ratings, price target and estimates.

ZTS analyst forecast

as of October 18, 2026
Analyst consensus
Buy
3.65 / 5 from 17 analysts
Price target
$94.43
average of analyst targets
Upside to target
+19.0%
from the latest close
Next earnings
November 5, 2026
EPS estimate $1.51
52-week range
$69.10 – $147.53

ZTS analyst ratings

17 analysts
Strong buy
424%
Buy
318%
Hold
1059%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

ZTS price target

Price $79.38Target $94.43
52-week low $69.1052-week high $147.53

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

ZTS earnings per share estimates

Zoetis Inc. EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current quarter (Sep '26)$1.51$1.44$1.61$1.70−11.4%13
Current fiscal year (2026)$6.21$6.17$6.27$6.41−3.1%14
Next fiscal year (2027)$6.55$6.07$7.62$6.21+5.4%16

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

ZTS revenue estimates

Zoetis Inc. revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current quarter (Sep '26)$2.30B$2.24B$2.35B−4.2%11
Current fiscal year (2026)$9.25B$9.10B$9.37B−2.3%13
Next fiscal year (2027)$9.48B$8.91B$10.50B+2.5%15

ZTS EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

ZTS revenue: reported and forecast

Reported revenueEstimate (average; low–high)

ZTS EPS estimate revisions

Zoetis Inc. EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current quarter (Sep '26)$1.84$1.55$1.51$1.51$1.51−18.3%0 up · 13 down
Current fiscal year (2026)$6.87$6.29$6.21$6.21$6.21−9.6%0 up · 15 down
Next fiscal year (2027)$7.39$6.69$6.53$6.54$6.55−11.4%0 up · 15 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

ZTS earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; ZTS beat in 10 of 12.

What analysts expect from ZTS

17 analysts cover Zoetis; their consensus rating is buy (3.65 on a 1–5 scale, where 5 is a strong buy). The average price target is $94.43, 19.0% above the latest close of $79.38. Analysts expect earnings of $6.21 per share for 2026, −3.1% from a year earlier. For 2027 the average estimate is $6.55 per share on revenue of $9.5 billion. Zoetis beat the EPS estimate in 10 of the last 12 quarters.

Related: ZTS income statement, ZTS key metrics, ZTS chart. See the ZTS stock overview for the latest quote and news.

ZTS forecast FAQ

What is Zoetis's price target?

The average analyst price target for Zoetis is $94.43, 19.0% above the latest close of $79.38.

Is Zoetis a buy, hold or sell?

Of 17 analysts covering Zoetis, 4 rate it a strong buy, 3 a buy, 10 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.

What is Zoetis's EPS forecast?

Analysts forecast $6.21 per share for 2026 (range $6.17 to $6.27); for 2027 the estimate is $6.55.

What is Zoetis's revenue forecast?

The average revenue estimate for 2026 is $9.3 billion, growth of −2.3%; for 2027 it is $9.5 billion.

When does Zoetis report earnings?

Zoetis is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 before the market opens; the EPS estimate is $1.51.

Does Zoetis usually beat earnings estimates?

Zoetis reported EPS at or above the analyst estimate in 10 of the last 12 quarters.

Drug Manufacturers - Specialty & Generic: forecast